Time for American Health Agencies to Factor in Natural Immunity for Precision Vaccination

Why does the entire American society need a COVID-19 vaccine if evidence increasingly indicates natural immunity is just as if not superior in boosting immunity? After all, by May 2021, a third of the U.S. population, estimated at 44% of adults aged 18-50, had already been infected, suggests Centers for Disease Control and Prevention (CDC) data. With the confluence of massive numbers of already infected persons on the one hand and mounting evidence as to superiority of natural immunity, why haven't health agency decision-makers factored natural immunity into decision making associated with the prioritization of vaccination? Why can't the CDC at least establish a protocol that those that have been infected wait at least eight months? Or why not follow the recommendation of Florian Krammer,  Icahn School of Medicine, who suggested to the New York Times that it would be prudent to administer only one dose to individuals who have already recovered from a SARS-CoV-2 infection. Or there is the well-known Marty Makary, the outspoken Johns Hopkins University professor and MedPage Today editor who recently declared why vaccinate everyone—even those with immunity—when the focus sh...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee